Kunal Malik Selected Research

Congenital Ichthyosiform Erythroderma

1/2022	Transcriptomic Analysis of the Major Orphan Ichthyosis Subtypes Reveals Shared Immune and Barrier Signatures.
1/2019	Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kunal Malik Research Topics

Disease

9	Atopic Dermatitis (Atopic Eczema) 12/2020 - 01/2017
4	Hyperplasia 01/2019 - 10/2017
3	Ichthyosis (Xeroderma) 01/2022 - 10/2018
3	Neoplasms (Cancer) 03/2021 - 02/2015
3	Alopecia Areata 12/2020 - 01/2018
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 01/2017
2	Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma) 01/2022 - 01/2019
2	Lamellar Ichthyosis (Harlequin Ichthyosis) 01/2022 - 01/2019
2	Netherton Syndrome 01/2022 - 01/2019
2	Congenital Ichthyosiform Erythroderma 01/2022 - 01/2019
1	Vitreous Hemorrhage 03/2021
1	Necrosis 03/2021
1	Uveal melanoma 03/2021
1	Melanoma (Melanoma, Malignant) 03/2021
1	COVID-19 02/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Rupture 01/2021
1	Retinoblastoma (Glioblastoma, Retinal) 01/2020
1	Glaucoma 12/2019
1	Diarrhea 01/2019
1	Headache (Headaches) 01/2019
1	Nasopharyngitis 01/2019
1	Nausea 01/2019
1	Dermatitis 01/2018
1	Eczema 01/2018
1	Skin Diseases (Skin Disease) 01/2018
1	Carcinogenesis 11/2017
1	Atherosclerosis 01/2017
1	Chronic Hepatitis C 01/2016

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
3	Filaggrin ProteinsIBA 01/2019 - 01/2018
3	loricrinIBA 01/2019 - 01/2018
3	CytokinesIBA 01/2019 - 01/2018
2	Retinaldehyde (Retinal)IBA 03/2021 - 01/2020
2	fezakinumabIBA 01/2019 - 01/2018
2	LipidsIBA 01/2019 - 01/2018
2	Interleukin-22 (IL-22)IBA 01/2019 - 01/2018
2	Keratin-16 (Keratin 16)IBA 01/2019 - 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Iodine-125IBA 03/2021
1	Melphalan (Alkeran)FDA LinkGeneric 03/2021
1	Capsules (Microcapsules)IBA 01/2021
1	dupilumabIBA 12/2020
1	Ophthalmic Solutions (Eye Drops)IBA 12/2019
1	apremilastIBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	GalaninIBA 01/2019
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2019
1	Fatty Acid ElongasesIBA 01/2019
1	Inducible T-Cell Co-Stimulator ProteinIBA 01/2019
1	kynureninaseIBA 01/2019
1	Claudin-1IBA 01/2019
1	DefensinsIBA 01/2019
1	6-sulfo sialyl Lewis XIBA 10/2018
1	Liver X ReceptorsIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Sterol Regulatory Element Binding Protein 1IBA 01/2018
1	NucleotidesIBA 11/2017
1	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 10/2017
1	SteroidsIBA 10/2017
1	pimecrolimus (Elidel)FDA Link 10/2017
1	Differentiation AntigensIBA 10/2017
1	Macrophage Colony-Stimulating FactorIBA 01/2017
1	CD40 Ligand (CD40L)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Chemokine CX3CL1IBA 01/2017
1	Antiviral Agents (Antivirals)IBA 01/2016

Therapy/Procedure

4	Therapeutics 01/2020 - 02/2015
2	Radiotherapy 03/2021 - 01/2020
1	Injections 03/2021
1	Surgical Instruments (Clip) 02/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Laser Therapy (Surgery, Laser) 12/2019